Synthetic cannabinoids further rift between marijuana and hemp industries
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug…
News March 13A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug…
News March 13Medical groups in Virginia are asking the governor to sign a bill as written that adds new restrictions to…
News March 10A ruling by a cannabis social equity oversight board in Connecticut has significantly altered the landscape for a…
News March 10After witnessing a blowout loss in Oklahoma on Tuesday, advocates of adult-use marijuana legalization are turning their attention…
News March 10While some marijuana companies are exiting California's difficult, regulated market - Curaleaf Holdings is among the most notable…
News March 9Efforts to cap the potency of cannabis products in Washington state and limit high-potency THC to the medical…
News March 3California’s top cannabis regulator has boosted and improved enforcement of illicit marijuana operations the past two years, according…
News March 3British Columbia-based cannabis company Adastra Labs has been approved by Health Canada to possess, produce, sell and distribute…
News March 3Are the go-go days of Oklahoma's medical marijuana industry over, or are Texans about to receive a grand…
News March 3A medical marijuana patient in Arkansas is suing three medical cannabis cultivators and a lab in the state,…
News March 2